Nektar Therapeutics (NKTR)

84.49 -0.60 (-0.71%) USD  |  NASDAQ  |  May 07, 10:11
More

Nektar Therapeutics Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for NKTR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Boston Scientific Corp. Upgrade
Eli Lilly & Co. Upgrade
Soleno Therapeutics, Inc. Upgrade
Aquestive Therapeutics, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade